TY - JOUR
T1 - Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease
AU - Divekar, Abhay A.
AU - Arar, Yousef M.
AU - Clark, Stephen
AU - Tandon, Animesh
AU - Zellers, Thomas M.
AU - Veeram Reddy, Surendranath R.
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/4
Y1 - 2022/4
N2 - Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use of devices is common and appropriate, a growing number of devices are now specifically designed and approved for use in CHD. Advanced imaging is now an integral part of interventional procedures including pre-procedure planning, intra-procedural guidance, and post-procedure monitoring. There is robust societal and industrial support for research and development of CHD-specific devices, and the regulatory framework at the national and international level is patient friendly. It is against this backdrop that we review transcatheter implantable devices for CHD, the role and integration of advanced imaging, and explore the current regulatory framework for device approval.
AB - Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use of devices is common and appropriate, a growing number of devices are now specifically designed and approved for use in CHD. Advanced imaging is now an integral part of interventional procedures including pre-procedure planning, intra-procedural guidance, and post-procedure monitoring. There is robust societal and industrial support for research and development of CHD-specific devices, and the regulatory framework at the national and international level is patient friendly. It is against this backdrop that we review transcatheter implantable devices for CHD, the role and integration of advanced imaging, and explore the current regulatory framework for device approval.
KW - Septal Occluders
KW - congenital heart disease
KW - cross-sectional imaging
KW - stents
KW - transcatheter intervention
KW - transcatheter pulmonary valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85128276060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128276060&partnerID=8YFLogxK
U2 - 10.3390/children9040497
DO - 10.3390/children9040497
M3 - Review article
C2 - 35455541
AN - SCOPUS:85128276060
SN - 2227-9067
VL - 9
JO - Children
JF - Children
IS - 4
M1 - 497
ER -